Systems biology in systemic lupus erythematosus: Integrating genes, biology and immune function

Autoimmunity

Volumn 39, Issue 8, 2006, Pages 705-709

  Kyttaris, Vasileios C ^a   Krishnan, Sandeep ^a   Tsokos, George C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Allelic variants; Autoimmunity; Biomarkers; Signal transduction; SLE

Indexed keywords

ALLELE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HUMAN; IMMUNE DYSREGULATION; IMMUNE SYSTEM; INNATE IMMUNITY; PATHOGENESIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMS BIOLOGY; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 33845713350     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930601061363     Document Type: Article

References (45)

1. Tsao, BP. (2004) Update on human systemic lupus erythematosus genetics Curr Opin Rheumatol, 16, pp. 513-521.
2. Graham, RR and Ortmann, WA and Langefeld, CD and Jawaheer, D and Selby, SA and Rodine, PR and (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus Am J Hum Genet, 71, pp. 543-553.
3. Salomon, B and Bluestone, JA. (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol, 19, pp. 225-252.
4. Baroja, ML and Vijayakrishnan, L and Bettelli, E and Darlington, PJ and Chau, TA and Ling, V and (2002) Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A J Immunol, 168, pp. 5070-5078.
5. Hudson, LL and Rocca, K and Song, YW and Pandey, JP. (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: A highly significant association with a determinant in the promoter region Hum Genet, 111, pp. 452-455.
6. Kyogoku, C and Langefeld, CD and Ortmann, WA and Lee, A and Selby, S and Carlton, VE and (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE Am J Hum Genet, 75, pp. 504-507.
7. Cloutier, JF and Veillette, A. (1996) Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells EMBO J, 15, pp. 4909-4918.
8. Cloutier, JF and Veillette, A. (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase J Exp Med, 189, pp. 111-121.
9. Liossis, SN and Ding, XZ and Dennis, GJ and Tsokos, GC. (1998) Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain J Clin Invest, 101, pp. 1448-1457.
10. Gergely, P, Jr. and Niland, B and Gonchoroff, N and Pullmann, R, Jr. and Phillips, PE and Perl, A. (2002) Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus J Immunol, 169, pp. 1092-1101.
11. Krishnan, S and Nambiar, MP and Warke, VG and Fisher, CU and Mitchell, J and Delaney, N and (2004) Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus J Immunol, 172, pp. 7821-7831.
12. Krishnan, S and Warke, VG and Nambiar, MP and Tsokos, GC and Farber, DL. (2003) The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells J Immunol, 170, pp. 4189-4195.
13. Tsokos, GC and Nambiar, MP and Tenbrock, K and Juang, YT. (2003) Rewiring the T-cell: Signaling defects and novel prospects for the treatment of SLE Trends Immunol, 24, pp. 259-263.
14. Juang, YT and Tenbrock, K and Nambiar, MP and Gourley, MF and Tsokos, GC. (2002) Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus J Immunol, 169, pp. 6048-6055.
15. Chowdhury, B and Tsokos, CG and Krishnan, S and Robertson, J and Fisher, CU and Warke, RG and (2005) Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3′-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus J Biol Chem, 280, pp. 18959-18966.
16. Tsuzaka, K and Setoyama, Y and Yoshimoto, K and Shiraishi, K and Suzuki, K and Abe, T and (2005) A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells J Immunol, 174, pp. 3518-3525.
17. Linker-Israeli, M and Bakke, AC and Kitridou, RC and Gendler, S and Gillis, S and Horwitz, DA. (1983) Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE) J Immunol, 130, pp. 2651-2655.
18. Solomou, EE and Juang, YT and Gourley, MF and Kammer, GM and Tsokos, GC. (2001) Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus J Immunol, 166, pp. 4216-4222.
19. Tenbrock, K and Juang, YT and Gourley, MF and Nambiar, MP and Tsokos, GC. (2002) Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus J Immunol, 169, pp. 4147-4152.
20. Kyttaris, VC and Juang, YT and Tenbrock, K and Weinstein, A and Tsokos, GC. (2004) Cyclic adenosine 5′-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus J Immunol, 173, pp. 3557-3563.
21. Katsiari, CG and Kyttaris, VC and Juang, YT and Tsokos, GC. (2005) Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus J Clin Invest, 115, pp. 3193-3204.
22. Miyara, M and Amoura, Z and Parizot, C and Badoual, C and Dorgham, K and Trad, S and (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus J Immunol, 175, pp. 8392-8400.
23. Xu, L and Zhang, L and Yi, Y and Kang, HK and Datta, SK. (2004) Human lupus T cells resist inactivation and escape death by upregulating COX-2 Nat Med, 10, pp. 411-415.
24. Desai-Mehta, A and Lu, L and Ramsey-Goldman, R and Datta, SK. (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production J Clin Invest, 97, pp. 2063-2073.
25. Liossis, SN and Kovacs, B and Dennis, G and Kammer, GM and Tsokos, GC. (1996) B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events J Clin Invest, 98, pp. 2549-2557.
26. Enyedy, EJ and Mitchell, JP and Nambiar, MP and Tsokos, GC. (2001) Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus Clin Immunol, 101, pp. 130-135.
27. Mackay, M and Stanevsky, A and Wang, T and Aranow, C and Li, M and Koenig, S and (2006) Selective dysregulation of the Fc{gamma}IIB receptor on memory B cells in SLE J Exp Med, 203, pp. 2157-2164.
28. Nagy, G and Koncz, A and Perl, A. (2005) T- and B-cell abnormalities in systemic lupus erythematosus Crit Rev Immunol, 25, pp. 123-140.
29. Juang, YT and Wang, Y and Solomou, EE and Li, Y and Mawrin, C and Tenbrock, K and (2005) Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV J Clin Invest, 115, pp. 996-1005.
30. Ghebrehiwet, B and Peerschke, EI. (2004) Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus Curr Dir Autoimmun, 7, pp. 87-97.
31. Slingsby, JH and Norsworthy, P and Pearce, G and Vaishnaw, AK and Issler, H and Morley, BJ and (1996) Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families Arthritis Rheum, 39, pp. 663-670.
32. Manderson, AP and Botto, M and Walport, MJ. (2004) The role of complement in the development of systemic lupus erythematosus Annu Rev Immunol, 22, pp. 431-456.
33. Mevorach, D and Mascarenhas, JO and Gershov, D and Elkon, KB. (1998) Complement-dependent clearance of apoptotic cells by human macrophages J Exp Med, 188, pp. 2313-2320.
34. Senaldi, G and Davies, ET and Peakman, M and Vergani, D and Lu, J and Reid, KB. (1995) Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus Arthritis Rheum, 38, pp. 1713-1714.
35. Sullivan, KE and Wooten, C and Goldman, D and Petri, M. (1996) Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus Arthritis Rheum, 39, pp. 2046-2051.
36. Kyogoku, C and Dijstelbloem, HM and Tsuchiya, N and Hatta, Y and Kato, H and Yamaguchi, A and (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility Arthritis Rheum, 46, pp. 1242-1254.
37. Salmon, JE and Pricop, L. (2001) Human receptors for immunoglobulin G: Key elements in the pathogenesis of rheumatic disease Arthritis Rheum, 44, pp. 739-750.
38. Karassa, FB and Trikalinos, TA and Ioannidis, JP. (2002) Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: A meta-analysis Arthritis Rheum, 46, pp. 1563-1571.
39. Karassa, FB and Trikalinos, TA and Ioannidis, JP. (2003) The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis Kidney Int, 63, pp. 1475-1482.
40. Russell, AI and Cunninghame Graham, DS and Shepherd, C and Roberton, CA and Whittaker, J and Meeks, J and (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus Hum Mol Genet, 13, pp. 137-147.
41. Bharadwaj, D and Stein, MP and Volzer, M and Mold, C and Du Clos, TW. (1999) The major receptor for C-reactive protein on leukocytes is fcgamma receptor II J Exp Med, 190, pp. 585-590.
42. Yasutomo, K and Horiuchi, T and Kagami, S and Tsukamoto, H and Hashimura, C and Urushihara, M and (2001) Mutation of DNASE1 in people with systemic lupus erythematosus Nat Genet, 28, pp. 313-314.
43. Wilson, AG and Gordon, C and di Giovine, FS and de Vries, N and van de Putte, LB and Emery, P and (1994) A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha Eur J Immunol, 24, pp. 191-195.
44. Morita, C and Horiuchi, T and Tsukamoto, H and Hatta, N and Kikuchi, Y and Arinobu, Y and (2001) Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese: Molecular and functional analysis Arthritis Rheum, 44, pp. 2819-2827.
45. D'Alfonso, S and Rampi, M and Bocchio, D and Colombo, G and Scorza-Smeraldi, R and Momigliano-Richardi, P. (2000) Systemic lupus erythematosus candidate genes in the Italian population: Evidence for a significant association with interleukin-10 Arthritis Rheum, 43, pp. 120-128.